The global gait rehabilitation system market size was US$ 136.8 billion in 2021. The global gait rehabilitation system market is forecast to grow to US$ 225.8 billion by 2030, registering a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2022 to 2030.

The gait rehabilitation system is highly used to provide physical therapy interventions with a robotic approach. This physical therapy intends to improve functional ambulation and offer efficient training. These systems are a significant component of the therapy offered to patients suffering from movement disorders of the lower extremities.

Factors Influencing the Market

The growing number of cases related to stroke and neurological disorders are driving the growth of the global gait rehabilitation system market. In addition, growing technological advancements by prominent players are forecast to surge the market growth in the coming years. Furthermore, the increasing geriatric population is increasing the cases of neurological disorders, which is contributing to the market growth.
The growing adoption of gait rehabilitation systems in nutraceutical industries will benefit the market during the forecast period. In addition, the market will witness favorable opportunities due to growing investments by major market players in capsule manufacturing plants.
Increasing healthcare expenditure is forecast to fuel the growth of the global gait rehabilitation system market. Governments of various countries are increasing healthcare expenditure and investing highly in order to offer superior quality services. Therefore, the adoption of gait rehabilitation systems is likely to accelerate globally.
The high cost of the gait rehabilitation system may hamper the overall market growth.
COVID-19 Impact Analysis

The gait rehabilitation systems market suffered significant losses at the beginning of the COVID-19 crisis because of supply chain disruptions and lockdown restrictions imposed in most countries. COVID-19 has had a significant negative impact on the gait rehabilitation systems market. Moreover, the COVID-19 pandemic has deprived patients of taking neurological treatments. Moreover, self-rehabilitation became a progressive trend as people were not allowed to visit hospitals without COVID-19 tests.

Regional Analysis

North America is forecast to have maximum contribution in the global gait rehabilitation system market due to the growing penetration of advanced technologies. In addition, high healthcare expenditure and growing government initiatives to offer efficient healthcare services are likely to drive the regional market growth. Furthermore, the increasing prevalence of strokes, mostly among the geriatric population, is contributing to the market growth. Moreover, growing product launches and R&D Activities will fuel the growth of the regional gait rehabilitation system market during the forecast period.

Market Segmentation

The global gait rehabilitation system market segmentation focuses on Product, End-User, and Region.

By Product

Mechanical Type
Computer-aided
Others
By End-User

Hospital
Clinic
Rehabilitation Center
Other
By Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Competitors in the Market

Lonza
Pacific BioLabs
Charles River
Merck
Eurofins
Medicilon
GenScript
BioMrieux/Hyglos
Accugen Labs
Fujifilm
Steris
Nelson Laboratories
Other prominent players